2017
Vaccine, (2017).37 50
SAFETY AND IMMUNOGENICITY OF MONOVALENT AD26. ZEBOV AND MULTIVALENT MVA-BN-FILO HETEROLOGOUS PRIME-BOOST VACCINE REGIMENS AGAINST EBOLA IN AFRICAN HEALTHY ADULT VOLUNTEERS.
2017
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2017).97 5
2017
Journal of Health Inequalities, (2017).3 2
2017
Vaccine, (2017).35 32
2017
The Lancet infectious diseases, (2017).17 12
2017
Vaccine, (2017).35 32
2017
Practice Nursing, (2017).28 10
2017
BMC public health, (2017).17 1
2017
Clinical & translational immunology, (2017).6 10
2017
Papillomavirus research (Amsterdam, Netherlands), (2017).4,